GAAP Net Income from Continuing Operations during the Second Quarter of 2024 of $7.2 million versus Second Quarter 2023 GAAP loss of $28.9 million Adjusted EBITDA profitability for the Second Quarter ...

Company improves 2024 year-to-date GAAP Net Loss from Continuing Operations by $117.4 million year-over-year and year-to-date Adjusted EBITDA by $87.2 million year-over-year Increases Full-Year 2024 ...

Clover Health will announce Q4 and full year 2024 results on February 27, 2025, with a conference call at 5 PM ET. Clover Health Investments, Corp. announced that it will release its fourth quarter ...

Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income ...

We came across a bullish thesis on Clover Health Investments, Corp. on topsecretstocks’s Substack. In this article, we will ...

First Quarter 2024 GAAP Net Loss from Continuing Operations of $23.2 million versus First Quarter 2023 loss of $79.7 million First Quarter Adjusted EBITDA profitability of $6.8 million versus prior ...

Synchrony (NYSE: SYF), a leading consumer financial services company, today announced an expansion of its integration with Clover, the all-in-one commerce solution from Fiserv (NASDAQ: FISV). The ...